Quick Answer
Aptevo Therapeutics Inc. reported Common Stock Shares Outstanding of 997,830 shares for the year ending 2025.
- Aptevo Therapeutics Inc. showed an increase of +24,531.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Aptevo Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: 997,830 shares | Fiscal year 2024: 4,051 shares | Fiscal year 2023: 11,958 shares | Fiscal year 2022: 6.47 million shares | Fiscal year 2021: 4.90 million shares | Fiscal year 2020: 4.41 million shares | Fiscal year 2019: 3.23 million shares | Fiscal year 2018: 22.81 million shares | Fiscal year 2017: 21.61 million shares | Fiscal year 2016: 20.27 million shares | Fiscal year 2015: 0 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: